The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III safety evaluation of intravenous NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron, over multiple cycles.
 
Lee Steven Schwartzberg
Honoraria - Amgen; Bristol-Myers Squibb; Pfizer; Tesaro
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Helsinn Therapeutics; Pfizer
Speakers' Bureau - Genentech/Roche
Research Funding - Helsinn Therapeutics
 
Zoran Gojko Andric
No Relationships to Disclose
 
Dariusz Kowalski
No Relationships to Disclose
 
Daniel Voisin
Employment - Helsinn Healthcare
 
Giada Rizzi
Employment - Helsinn Healthcare
 
Meinolf Karthaus
Consulting or Advisory Role - Helsinn Healthcare; RIEMSER